306 related articles for article (PubMed ID: 34518609)
1. Efficient biallelic knock-in in mouse embryonic stem cells by in vivo-linearization of donor and transient inhibition of DNA polymerase θ/DNA-PK.
Arai D; Nakao Y
Sci Rep; 2021 Sep; 11(1):18132. PubMed ID: 34518609
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
3. A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.
Li X; Sun B; Qian H; Ma J; Paolino M; Zhang Z
J Zhejiang Univ Sci B; 2022 Feb; 23(2):141-152. PubMed ID: 35187887
[TBL] [Abstract][Full Text] [Related]
4. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
5. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
Zhang WW; Matlashewski G
mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
[TBL] [Abstract][Full Text] [Related]
6. Assays for DNA double-strand break repair by microhomology-based end-joining repair mechanisms.
Kostyrko K; Mermod N
Nucleic Acids Res; 2016 Apr; 44(6):e56. PubMed ID: 26657630
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9-Mediated Genome Modifications in Zebrafish.
Kamachi Y; Kawahara A
Methods Mol Biol; 2023; 2637():313-324. PubMed ID: 36773157
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-Mediated Targeted Knockin of Exogenous Reporter Genes in Zebrafish.
Kawahara A
Methods Mol Biol; 2017; 1630():165-173. PubMed ID: 28643258
[TBL] [Abstract][Full Text] [Related]
9. Combi-CRISPR: combination of NHEJ and HDR provides efficient and precise plasmid-based knock-ins in mice and rats.
Yoshimi K; Oka Y; Miyasaka Y; Kotani Y; Yasumura M; Uno Y; Hattori K; Tanigawa A; Sato M; Oya M; Nakamura K; Matsushita N; Kobayashi K; Mashimo T
Hum Genet; 2021 Feb; 140(2):277-287. PubMed ID: 32617796
[TBL] [Abstract][Full Text] [Related]
10. Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways.
Schimmel J; Muñoz-Subirana N; Kool H; van Schendel R; van der Vlies S; Kamp JA; de Vrij FMS; Kushner SA; Smith GCM; Boulton SJ; Tijsterman M
Cell Rep; 2023 Feb; 42(2):112019. PubMed ID: 36701230
[TBL] [Abstract][Full Text] [Related]
11. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.
Miyaoka Y; Berman JR; Cooper SB; Mayerl SJ; Chan AH; Zhang B; Karlin-Neumann GA; Conklin BR
Sci Rep; 2016 Mar; 6():23549. PubMed ID: 27030102
[TBL] [Abstract][Full Text] [Related]
12. Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.
Fu YW; Dai XY; Wang WT; Yang ZX; Zhao JJ; Zhang JP; Wen W; Zhang F; Oberg KC; Zhang L; Cheng T; Zhang XB
Nucleic Acids Res; 2021 Jan; 49(2):969-985. PubMed ID: 33398341
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous precise editing of multiple genes in human cells.
Riesenberg S; Chintalapati M; Macak D; Kanis P; Maricic T; Pääbo S
Nucleic Acids Res; 2019 Nov; 47(19):e116. PubMed ID: 31392986
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated targeted knock-in of large constructs using nocodazole and RNase HII.
Eghbalsaied S; Kues WA
Sci Rep; 2023 Feb; 13(1):2690. PubMed ID: 36792645
[TBL] [Abstract][Full Text] [Related]
15. Co-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells.
Shy BR; MacDougall MS; Clarke R; Merrill BJ
Nucleic Acids Res; 2016 Sep; 44(16):7997-8010. PubMed ID: 27484482
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone H2A-K15 ubiquitination.
Bashir S; Dang T; Rossius J; Wolf J; Kühn R
BMC Biotechnol; 2020 Oct; 20(1):57. PubMed ID: 33097066
[TBL] [Abstract][Full Text] [Related]
17. Targeted integration in human cells through single crossover mediated by ZFN or CRISPR/Cas9.
Liu X; Wang M; Qin Y; Shi X; Cong P; Chen Y; He Z
BMC Biotechnol; 2018 Oct; 18(1):66. PubMed ID: 30340581
[TBL] [Abstract][Full Text] [Related]
18. Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.
Li G; Zhang X; Zhong C; Mo J; Quan R; Yang J; Liu D; Li Z; Yang H; Wu Z
Sci Rep; 2017 Aug; 7(1):8943. PubMed ID: 28827551
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
20. Exogenous gene integration mediated by genome editing technologies in zebrafish.
Morita H; Taimatsu K; Yanagi K; Kawahara A
Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
